{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:42:07Z","timestamp":1778946127349,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12879-014-0667-0","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T11:03:28Z","timestamp":1418727808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2\u00a0year follow-up; a Norwegian prospective multicenter study"],"prefix":"10.1186","volume":"14","author":[{"given":"Nadine Durema","family":"Pullar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Steinum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan Nikolai","family":"Bruun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Ma","family":"Dyrhol-Riise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"667_CR1","volume-title":"Use of interferon-gamma assays in support of TB diagnosis","author":"European Centre for Disease Prevention and Control","year":"2011","unstructured":"European Centre for Disease Prevention and Control: Use of interferon-gamma assays in support of TB diagnosis. 2011, ECDC, Stockholm"},{"key":"667_CR2","volume-title":"Smittevern 20: Forebygging og Kontroll av Tuberkulose (Guidelines for prevention and control of tuberculosis)","author":"Folkehelseinstituttet","year":"2010","unstructured":"Folkehelseinstituttet: Smittevern 20: Forebygging og Kontroll av Tuberkulose (Guidelines for prevention and control of tuberculosis). 2010, The Norwegian Institute of Public Health, Oslo"},{"key":"667_CR3","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K: Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep. 2010, 59: 1-25.","journal-title":"MMWR Recomm Rep"},{"key":"667_CR4","volume-title":"Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control","author":"National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK)","year":"2011","unstructured":"National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK): Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. 2011, National Institute for Health and Clinical Excellence (UK), London, 117","edition":"117"},{"key":"667_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1465-9921-7-56","volume":"7","author":"I Brock","year":"2006","unstructured":"Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P: Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res. 2006, 7: 56-10.1186\/1465-9921-7-56.","journal-title":"Respir Res"},{"issue":"Suppl 4","key":"667_CR6","doi-asserted-by":"publisher","first-page":"S1120","DOI":"10.1093\/infdis\/jir410","volume":"204","author":"JZ Metcalfe","year":"2011","unstructured":"Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, Hopewell PC, Pai M: Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis. 2011, 204 (Suppl 4): S1120-S1129. 10.1093\/infdis\/jir410.","journal-title":"J Infect Dis"},{"key":"667_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1471-2334-12-169","volume":"12","author":"JM Ramos","year":"2012","unstructured":"Ramos JM, Robledano C, Masia M, Belda S, Padilla S, Rodriguez JC, Gutierrez F: Contribution of Interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: A comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test. BMC Infect Dis. 2012, 12: 169-10.1186\/1471-2334-12-169.","journal-title":"BMC Infect Dis"},{"key":"667_CR8","doi-asserted-by":"publisher","first-page":"e5718","DOI":"10.1371\/journal.pone.0005718","volume":"4","author":"KB Syed Ahamed","year":"2009","unstructured":"Syed Ahamed KB, Sikhamani R, Swaminathan S, Perumal V, Paramasivam P, Raja A: Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS One. 2009, 4: e5718-10.1371\/journal.pone.0005718.","journal-title":"PLoS One"},{"key":"667_CR9","doi-asserted-by":"publisher","first-page":"e32482","DOI":"10.1371\/journal.pone.0032482","volume":"7","author":"M Santin","year":"2012","unstructured":"Santin M, Munoz L, Rigau D: Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis. PLoS One. 2012, 7: e32482-10.1371\/journal.pone.0032482.","journal-title":"PLoS One"},{"key":"667_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","volume":"187","author":"JZ Metcalfe","year":"2013","unstructured":"Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, Graviss EA: Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med. 2013, 187: 206-211. 10.1164\/rccm.201203-0430OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"667_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/infdis\/jit418","volume":"209","author":"MC Aichelburg","year":"2014","unstructured":"Aichelburg MC, Reiberger T, Breitenecker F, Mandorfer M, Makristathis A, Rieger A: Reversion and Conversion of Interferon-gamma Release Assay Results in HIV-1-Infected Individuals. J Infect Dis. 2014, 209: 729-733. 10.1093\/infdis\/jit418.","journal-title":"J Infect Dis"},{"key":"667_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1086\/510080","volume":"44","author":"L Elzi","year":"2007","unstructured":"Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H: Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis. 2007, 44: 94-102. 10.1086\/510080.","journal-title":"Clin Infect Dis"},{"key":"667_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1183\/09031936.00115110","volume":"37","author":"R Diel","year":"2011","unstructured":"Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D: Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011, 37: 88-99. 10.1183\/09031936.00115110.","journal-title":"Eur Respir J"},{"key":"667_CR14","volume-title":"Tuberkulose i Norge 2010\u20132011. Med behandlingsresultater 2009\u20132010 (Tuberculosis in Norway 2010\u20132011. Treatment results 2009\u20132010). 2012","author":"T Arnesen","year":"2012","unstructured":"Arnesen T, Heldal E, Manns\u00e5ker T, Sandbu S, R\u00f8nning K, Eide K\u00c5: Tuberkulose i Norge 2010\u20132011. Med behandlingsresultater 2009\u20132010 (Tuberculosis in Norway 2010\u20132011. Treatment results 2009\u20132010). 2012. 2012, Folkehelseinstituttet, Oslo"},{"key":"667_CR15","volume-title":"HIV situasjonen i Norge per 31 desember 2012. (HIV in Norway per 31 december 2012)","author":"Folkehelseinstituttet","year":"2013","unstructured":"Folkehelseinstituttet: HIV situasjonen i Norge per 31 desember 2012. (HIV in Norway per 31 december 2012). 2013, The Norwegian Institute of Public Health, Oslo"},{"key":"667_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1471-2458-9-141","volume":"9","author":"I Harstad","year":"2009","unstructured":"Harstad I, Heldal E, Steinshamn SL, Garasen H, Jacobsen GW: Tuberculosis screening and follow-up of asylum seekers in Norway: a cohort study. BMC Public Health. 2009, 9: 141-10.1186\/1471-2458-9-141.","journal-title":"BMC Public Health"},{"key":"667_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5588\/ijtld.13.0276","volume":"18","author":"ND Pullar","year":"2014","unstructured":"Pullar ND, Steinum H, Tonby K, Heggelund L, Leiva RA, Ofstad R, Bruun JN, Dyrhol-Riise AM: Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway. Int J Tuberc Lung Dis. 2014, 18: 180-187. 10.5588\/ijtld.13.0276.","journal-title":"Int J Tuberc Lung Dis"},{"key":"667_CR18","doi-asserted-by":"publisher","first-page":"e8517","DOI":"10.1371\/journal.pone.0008517","volume":"4","author":"RN van Zyl-Smit","year":"2009","unstructured":"van Zyl-Smit RN, Zwerling A, Dheda K, Pai M: Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One. 2009, 4: e8517-10.1371\/journal.pone.0008517.","journal-title":"PLoS One"},{"key":"667_CR19","volume-title":"TB elimination: Targeted Tuberculosis Testing and Interpreting Tuberculin Skin Test Results","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention: TB elimination: Targeted Tuberculosis Testing and Interpreting Tuberculin Skin Test Results. 2011"},{"key":"667_CR20","volume-title":"Tuberculosis (TB) (Mycobacterium tuberculosis) 2009 Case definition","author":"National Notifiable Diseases Surveillance System (NNDSS)","year":"2013","unstructured":"National Notifiable Diseases Surveillance System (NNDSS): Tuberculosis (TB) (Mycobacterium tuberculosis) 2009 Case definition. 2013, Cenbers for Disease Control and Prevention, Atlanta, USA"},{"key":"667_CR21","doi-asserted-by":"publisher","first-page":"e53330","DOI":"10.1371\/journal.pone.0053330","volume":"8","author":"CN Cheallaigh","year":"2013","unstructured":"Cheallaigh CN, Fitzgerald I, Grace J, Singh GJ, El-Eraki N, Gibbons N, Keane J, Rogers TR, Clarke S, Bergin C: Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country. PLoS One. 2013, 8: e53330-10.1371\/journal.pone.0053330.","journal-title":"PLoS One"},{"key":"667_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1471-2334-12-107","volume":"12","author":"MM Kall","year":"2012","unstructured":"Kall MM, Coyne KM, Garrett NJ, Boyd AE, Ashcroft AT, Reeves I, Anderson J, Bothamley GH: Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study. BMC Infect Dis. 2012, 12: 107-10.1186\/1471-2334-12-107.","journal-title":"BMC Infect Dis"},{"key":"667_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/1403494809353823","volume":"38","author":"I Harstad","year":"2010","unstructured":"Harstad I, Heldal E, Steinshamn SL, Garasen H, Winje BA, Jacobsen GW: Screening and treatment of latent tuberculosis in a cohort of asylum seekers in Norway. Scand J Public Health. 2010, 38: 275-282. 10.1177\/1403494809353823.","journal-title":"Scand J Public Health"},{"key":"667_CR24","first-page":"CD000171","volume":"2010","author":"C Akolo","year":"2010","unstructured":"Akolo C, Adetifa I, Shepperd S, Volmink J: Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010, 2010: CD000171-","journal-title":"Cochrane Database Syst Rev"},{"key":"667_CR25","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1093\/cid\/cir792","volume":"54","author":"J Gray","year":"2012","unstructured":"Gray J, Reves R, Johnson S, Belknap R: Identification of false-positive QuantiFERON-TB Gold In-Tube assays by repeat testing in HIV-infected patients at low risk for tuberculosis. Clin Infect Dis. 2012, 54: e20-e23. 10.1093\/cid\/cir792.","journal-title":"Clin Infect Dis"},{"key":"667_CR26","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.tube.2013.07.006","volume":"93","author":"A Felber","year":"2013","unstructured":"Felber A, Graninger W: Weakly positive tests and chronologic variation of the QuantiFERON assay: A retrospective appraisal of usefulness. Tuberculosis (Edinb ). 2013, 93: 647-653. 10.1016\/j.tube.2013.07.006.","journal-title":"Tuberculosis (Edinb )"},{"key":"667_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1745-6673-7-6","volume":"7","author":"FC Ringshausen","year":"2012","unstructured":"Ringshausen FC, Schablon A, Nienhaus A: Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review. J Occup Med Toxicol. 2012, 7: 6-10.1186\/1745-6673-7-6.","journal-title":"J Occup Med Toxicol"},{"key":"667_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1468-1293.2011.00954.x","volume":"12","author":"AL Pozniak","year":"2011","unstructured":"Pozniak AL, Coyne KM, Miller RF, Lipman MCI, Freedman AR, Ormerod LP, Johnson MA, Collins S, Lucas SB: British HIV Association guidelines for the treatment of TB\/HIV coinfection 2011. HIV Medicine. 2011, 12: 517-524. 10.1111\/j.1468-1293.2011.00954.x.","journal-title":"HIV Medicine"},{"key":"667_CR29","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1086\/597351","volume":"48","author":"MC Aichelburg","year":"2009","unstructured":"Aichelburg MC, Rieger A, Breitenecker F, Pfistershammer K, Tittes J, Eltz S, Aichelburg AC, Stingl G, Makristathis A, Kohrgruber N: Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis. 2009, 48: 954-962. 10.1086\/597351.","journal-title":"Clin Infect Dis"},{"key":"667_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2249.2007.03477.x","volume":"150","author":"SA Clark","year":"2007","unstructured":"Clark SA, Martin SL, Pozniak A, Steel A, Ward B, Dunning J, Henderson DC, Nelson M, Gazzard B, Kelleher P: Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol. 2007, 150: 238-244. 10.1111\/j.1365-2249.2007.03477.x.","journal-title":"Clin Exp Immunol"},{"key":"667_CR31","first-page":"498","volume":"12","author":"D Menzies","year":"2008","unstructured":"Menzies D, Gardiner G, Farhat M, Greenaway C, Pai M: Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. Int J Tuberc Lung Dis. 2008, 12: 498-505.","journal-title":"Int J Tuberc Lung Dis"},{"key":"667_CR32","unstructured":"The Online TST\/IGRA Interpreter; 2013. \n                    http:\/\/www.tstin3d.com\/en\/calc.html\n                    \n                  ."},{"key":"667_CR33","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1164\/rccm.200511-1783OC","volume":"174","author":"K Ewer","year":"2006","unstructured":"Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A: Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2006, 174: 831-839. 10.1164\/rccm.200511-1783OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"667_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1471-2334-10-220","volume":"10","author":"FC Ringshausen","year":"2010","unstructured":"Ringshausen FC, Nienhaus A, Schablon A, Schlosser S, Schultze-Werninghaus G, Rohde G: Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers. BMC Infect Dis. 2010, 10: 220-10.1186\/1471-2334-10-220.","journal-title":"BMC Infect Dis"},{"key":"667_CR35","doi-asserted-by":"publisher","first-page":"e73069","DOI":"10.1371\/journal.pone.0073069","volume":"8","author":"CH Yang","year":"2013","unstructured":"Yang CH, Chan PC, Liao ST, Cheng SH, Wong WW, Huang LM, Hsueh PR, Chiou HY: Strategy to Better Select HIV-Infected Individuals for Latent TB Treatment in BCG-Vaccinated Population. PLoS One. 2013, 8: e73069-10.1371\/journal.pone.0073069.","journal-title":"PLoS One"},{"key":"667_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1164\/rccm.201208-1352OC","volume":"187","author":"IM Adetifa","year":"2013","unstructured":"Adetifa IM, Ota MO, Jeffries DJ, Lugos MD, Hammond AS, Battersby NJ, Owiafe PK, Donkor SD, Antonio M, Ibanga HB, Brookes RH, Aka P, Walton R, Adegbola RA, Hill PC: Interferon-gamma ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial. Am J Respir Crit Care Med. 2013, 187: 439-445. 10.1164\/rccm.201208-1352OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"667_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1183\/09031936.00151309","volume":"36","author":"CB Chee","year":"2010","unstructured":"Chee CB, KhinMar KW, Gan SH, Barkham TM, Koh CK, Shen L, Wang YT: Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens. Eur Respir J. 2010, 36: 355-361. 10.1183\/09031936.00151309.","journal-title":"Eur Respir J"},{"key":"667_CR38","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3109\/00365548.2010.482942","volume":"42","author":"J Idh","year":"2010","unstructured":"Idh J, Abate E, Westman A, Elias D, Janols H, Gelaw A, Getachew A, Alemu S, Aseffa A, Britton S, Stendahl O, Schon T: Kinetics of the QuantiFERON-TB Gold In-Tube test during treatment of patients with sputum smear-positive tuberculosis in relation to initial TST result and severity of disease. Scand J Infect Dis. 2010, 42: 650-657. 10.3109\/00365548.2010.482942.","journal-title":"Scand J Infect Dis"},{"key":"667_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jinf.2011.05.006","volume":"63","author":"K Komiya","year":"2011","unstructured":"Komiya K, Ariga H, Nagai H, Kurashima A, Shoji S, Ishii H, Ishii H, Nakajima Y: Reversion rates of QuantiFERON-TB Gold are related to pre-treatment IFN-gamma levels. J Infect. 2011, 63: 48-53. 10.1016\/j.jinf.2011.05.006.","journal-title":"J Infect"},{"key":"667_CR40","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/1471-2334-10-300","volume":"10","author":"SW Lee","year":"2010","unstructured":"Lee SW, Lee CT, Yim JJ: Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. BMC Infect Dis. 2010, 10: 300-10.1186\/1471-2334-10-300.","journal-title":"BMC Infect Dis"},{"key":"667_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-2334-9-105","volume":"9","author":"N Winqvist","year":"2009","unstructured":"Winqvist N, Bjorkman P, Noren A, Miorner H: Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area. BMC Infect Dis. 2009, 9: 105-10.1186\/1471-2334-9-105.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-014-0667-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0667-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0667-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0667-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:44:01Z","timestamp":1551167041000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-014-0667-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1186\/s12879-014-0667-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"17 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"667"}}